Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06396039
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-04-29
Brief Title:
A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-29
First Submit QC Date:
April 29 2024
Study First Post Date:
2024-05-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-07-01
Last Update Post Date Type:
ACTUAL